3,690
edits
TYK81: Difference between revisions
no edit summary
m (1 revision imported) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Alprostadil (PGE1) is associated with all of the following EXCEPT: | Alprostadil (PGE1) is associated with all of the following EXCEPT: | ||
| Line 11: | Line 10: | ||
D. Fluid retention | D. Fluid retention | ||
<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div> | |||
<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer"> | |||
<div class="mw-collapsible- | |||
==Answer== | ==Answer== | ||
The answer is A. | The answer is A. | ||
PGE1 infusion is associated with apnea, pyrexia, fluid retention, and platelet dysfunction, which are largely dosage dependent. Good things to remember when picking up the kid from the NICU. | PGE1 infusion is associated with apnea, pyrexia, fluid retention, and platelet dysfunction, which are largely dosage dependent. Good things to remember when picking up the kid from the NICU. | ||
==Notes== | ==Notes== | ||
<references /> | <references /> | ||
==Keywords== | ==Keywords== | ||
</div> | </div> | ||
---- | ---- | ||
---- | ---- | ||